Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes

By LabMedica International staff writers
Posted on 03 Jul 2025

Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. More...

It significantly heightens the risk of complications such as gestational hypertension, polyhydramnios, and cesarean delivery for the mother, while increasing the likelihood of birth asphyxia and long-term health conditions like obesity and diabetes in children. Early diagnosis and intervention are key to reducing these risks, yet current diagnostic methods often detect the disorder only after complications have begun to develop. In a new study, researchers identified early-pregnancy gut microbiota signatures that may serve as predictive biomarkers, paving the way for non-invasive early diagnosis of gestational diabetes.

In the study, researchers from Zhujiang Hospital of Southern Medical University (Guangzhou, China), along with collaborators, analyzed fecal microbiota from 61 pregnant women in their first trimester using 16S rRNA gene sequencing, a method that profiles bacterial communities at high resolution. They then correlated these microbiome profiles with oral glucose tolerance test results conducted between 24 to 28 weeks of gestation and with recorded clinical delivery outcomes. Through this process, the researchers were able to detect gut microbiota dysbiosis associated with the future onset of gestational diabetes. Using genus-level microbial markers, they developed an early diagnostic model designed to identify the condition well before traditional symptoms emerge.

The findings, published in Microbiology Spectrum, revealed significant differences in gut microbiota composition between women who developed gestational diabetes and those who did not. The diagnostic model demonstrated high predictive accuracy, supporting the potential of microbiome-based tools for early, non-invasive detection. The findings suggest that this approach could enable earlier intervention, offering better prevention and personalized care strategies to reduce adverse maternal and fetal outcomes. The researchers plan to refine and validate their model further across larger populations, with the long-term aim of integrating gut microbiota screening into routine prenatal care.

“These findings suggest that microbiota-based tools could enable early, non-invasive detection of gestational diabetes mellitus, offering new opportunities for prevention and personalized management,” wrote the study authors. “This research highlights the role of the gut microbiome in pregnancy and has important implications for improving maternal and fetal health outcomes.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.